Cynapsus Thera Cm Sh (CYNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,068 | 68,622 | 75,803 | 83,784 | 90,658 |
| TOTAL | $56,150 | $69,122 | $76,432 | $84,756 | $91,117 |
| Non-Current Assets | |||||
| PPE Net | 473 | 471 | 409 | 300 | 315 |
| Intangibles | 16,273 | 372 | 381 | 412 | 448 |
| TOTAL | $16,746 | $842 | $790 | $712 | $763 |
| Total Assets | $72,896 | $69,964 | $77,221 | $85,469 | $91,879 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,243 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,395 | 3,659 | 3,799 | 3,287 | 3,639 |
| TOTAL | $12,638 | $3,659 | $3,799 | $3,287 | $3,639 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,997 | N/A | N/A | N/A | N/A |
| TOTAL | $2,997 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $15,636 | $3,659 | $3,799 | $3,287 | $3,639 |
| Shareholders' Equity | |||||
| Common Shares | 120,024 | 119,891 | 119,565 | 107,766 | 114,207 |
| Retained earnings | -70,962 | -60,789 | -52,433 | -39,360 | -39,502 |
| Other shareholders' equity | 8,199 | 7,203 | 6,290 | 13,775 | 13,534 |
| TOTAL | $57,261 | $66,305 | $73,422 | $82,181 | $88,240 |
| Total Liabilities And Equity | $72,896 | $69,964 | $77,221 | $85,469 | $91,879 |